|
1
|
Wozney JM, Rosen V, Celeste AJ, et al:
Novel regulators of bone formation: molecular clones and
activities. Science. 242:1528–1534. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hogan BL: Bone morphogenetic proteins:
multifunctional regulators of vertebrate development. Genes Dev.
10:1580–1594. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reddi AH: Role of morphogenetic proteins
in skeletal tissue engineering and regeneration. Nat Biotechnol.
16:247–252. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hoodless PA, Haerry T, Abdollah S, et al:
MADR1, a MAD-related protein that functions in BMP2 signaling
pathways. Cell. 85:489–500. 1996. View Article : Google Scholar
|
|
5
|
Nohe A, Hassel S, Ehrlich M, et al: The
mode of bone morphogenetic protein (BMP) receptor oligomerization
determines different BMP-2 signaling pathways. J Biol Chem.
277:5330–5338. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu F, Ventura F, Doody J and Massague J:
Human type II receptor for bone morphogenic proteins (BMPs):
extension of the two-kinase receptor model to the BMPs. Mol Cell
Biol. 15:3479–3486. 1995.PubMed/NCBI
|
|
7
|
Nohno T, Ishikawa T, Saito T, et al:
Identification of a human type II receptor for bone morphogenetic
protein-4 that forms differential heteromeric complexes with bone
morphogenetic protein type I receptors. J Biol Chem.
270:22522–22526. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rosenzweig BL, Imamura T, Okadome T, et
al: Cloning and characterization of a human type II receptor for
bone morphogenetic proteins. Proc Natl Acad Sci USA. 92:7632–7636.
1995. View Article : Google Scholar
|
|
9
|
Massague J and Chen YG: Controlling
TGF-beta signaling. Genes Dev. 14:627–644. 2000.
|
|
10
|
Attisano L and Wrana JL: Smads as
transcriptional co-modulators. Curr Opin Cell Biol. 12:235–243.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kimura N, Matsuo R, Shibuya H, Nakashima K
and Taga T: BMP2-induced apoptosis is mediated by activation of the
TAK1-p38 kinase pathway that is negatively regulated by Smad6. J
Biol Chem. 275:17647–17652. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee KS, Hong SH and Bae SC: Both the Smad
and p38 MAPK pathways play a crucial role in Runx2 expression
following induction by transforming growth factor-beta and bone
morphogenetic protein. Oncogene. 21:7156–7163. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guicheux J, Lemonnier J, Ghayor C, Suzuki
A, Palmer G and Caverzasio J: Activation of p38 mitogen-activated
protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their
implication in the stimulation of osteoblastic cell
differentiation. J Bone Miner Res. 18:2060–2068. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Johnsen IK, Kappler R, Auernhammer CJ and
Beuschlein F: Bone morphogenetic proteins 2 and 5 are
down-regulated in adrenocortical carcinoma and modulate adrenal
cell proliferation and steroidogenesis. Cancer Res. 69:5784–5792.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ghosh Choudhury G, Kim YS, Simon M, et al:
Bone morphogenetic protein 2 inhibits platelet-derived growth
factor-induced c-fos gene transcription and DNA synthesis in
mesangial cells. Involvement of mitogen-activated protein kinase. J
Biol Chem. 274:10897–10902. 1999.
|
|
16
|
Wong GA, Tang V, El-Sabeawy F and Weiss
RH: BMP-2 inhibits proliferation of human aortic smooth muscle
cells via p21Cip1/Waf1. Am J Physiol Endocrinol Metab.
284:E972–E979. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Reinholz MM, Iturria SJ, Ingle JN and
Roche PC: Differential gene expression of TGF-beta family members
and osteopontin in breast tumor tissue: analysis by real-time
quantitative PCR. Breast Cancer Res Treat. 74:255–269. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Alarmo EL and Kallioniemi A: Bone
morphogenetic proteins in breast cancer: dual role in
tumourigenesis? Endocr Relat Cancer. 17:R123–R139. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ghosh-Choudhury N, Ghosh-Choudhury G,
Celeste A, et al: Bone morphogenetic protein-2 induces cyclin
kinase inhibitor p21 and hypophosphorylation of retinoblastoma
protein in estradiol-treated MCF-7 human breast cancer cells.
Biochim Biophys Acta. 1497:186–196. 2000. View Article : Google Scholar
|
|
20
|
Ghosh-Choudhury N, Woodruff K, Qi W,
Celeste A, Abboud SL and Ghosh Choudhury G: Bone morphogenetic
protein-2 blocks MDA MB 231 human breast cancer cell proliferation
by inhibiting cyclin-dependent kinase-mediated retinoblastoma
protein phosphorylation. Biochem Biophys Res Commun. 272:705–711.
2000. View Article : Google Scholar
|
|
21
|
Raida M, Clement JH, Ameri K, Han C, Leek
RD and Harris AL: Expression of bone morphogenetic protein 2 in
breast cancer cells inhibits hypoxic cell death. Int J Oncol.
26:1465–1470. 2005.PubMed/NCBI
|
|
22
|
Steinert S, Kroll TC, Taubert I, et al:
Differential expression of cancer-related genes by single and
permanent exposure to bone morphogenetic protein 2. J Cancer Res
Clin Oncol. 134:1237–1245. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pouliot F, Blais A and Labrie C:
Overexpression of a dominant negative type II bone morphogenetic
protein receptor inhibits the growth of human breast cancer cells.
Cancer Res. 63:277–281. 2003.PubMed/NCBI
|
|
24
|
Alarmo EL, Parssinen J, Ketolainen JM,
Savinainen K, Karhu R and Kallioniemi A: BMP7 influences
proliferation, migration, and invasion of breast cancer cells.
Cancer Lett. 275:35–43. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim M and Choe S: BMPs and their clinical
potentials. BMB Rep. 44:619–634. 2011. View Article : Google Scholar
|
|
26
|
Harper JW, Adami GR, Wei N, Keyomarsi K
and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent
inhibitor of G1 cyclin-dependent kinases. Cell. 75:805–816. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fong S, Itahana Y, Sumida T, et al: Id-1
as a molecular target in therapy for breast cancer cell invasion
and metastasis. Proc Natl Acad Sci USA. 100:13543–13548. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Clement JH, Marr N, Meissner A, et al:
Bone morphogenetic protein 2 (BMP-2) induces sequential changes of
Id gene expression in the breast cancer cell line MCF-7. J Cancer
Res Clin Oncol. 126:271–279. 2000. View Article : Google Scholar : PubMed/NCBI
|
